Covered recipient · General Payments record
NGOZI MARTHA EBOH
General Payments · PY2023–2024
$264.90
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.53 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $50.09 | 3 |
| Biogen, Inc. | $24.77 | 1 |
| PFIZER INC. | $24.60 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.96 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.38 | 1 |
| Merck Sharp & Dohme Corporation | $20.03 | 1 |
| Exact Sciences Corporation | $19.72 | 1 |
| Novo Nordisk AS | $19.26 | 1 |
| Mylan Specialty L.P. | $17.72 | 1 |
| ABBVIE INC. | $14.55 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.55 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107058248 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.38 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086313725 | CMS |
| Biogen, Inc. | $24.77 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831874 | CMS |
| Exact Sciences Corporation | $19.72 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128386331 | CMS |
| Lilly USA, LLC | $17.47 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135905617 | CMS |
| Lilly USA, LLC | $14.06 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135912035 | CMS |
| Lilly USA, LLC | $18.56 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917181 | CMS |
| Merck Sharp & Dohme LLC | $20.03 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141724062 | CMS |
| Mylan Specialty L.P. | $17.72 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147371541 | CMS |
| Novartis Pharmaceuticals Corporation | $14.45 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086960907 | CMS |
| Novo Nordisk Inc | $19.26 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100332268 | CMS |
| PFIZER INC. | $24.60 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130907216 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.96 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151162822 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.